Haiyong Wang

机构：Beijing Biocytogen (China), Shandong First Medical University, First Affiliated Hospital Zhejiang University · ORCID：0000-0003-0124-5301

发表论文 107 篇 · 总被引 2818 次 · h-index 34

代表论文

• Adenosine in cancer immunotherapy: Taking off on a new plane (2023 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 被引 77)
• Circumventing drug resistance in gastric cancer: A spatial multi-omics exploration of chemo and immuno-therapeutic response dynamics (2024 · Drug Resistance Updates · 被引 70)
• Anti‐PD‐1/Her2 Bispecific Antibody IBI315 Enhances the Treatment Effect of Her2‐Positive Gastric Cancer through Gasdermin B‐Cleavage Induced Pyroptosis (2023 · Advanced Science · 被引 53)
• PD-L1: Biological mechanism, function, and immunotherapy in gastric cancer (2022 · Frontiers in Immunology · 被引 43)
• Proteomic profiling of gastric cancer with peritoneal metastasis identifies a protein signature associated with immune microenvironment and patient outcome (2023 · Gastric Cancer · 被引 25)
• E2F1 Reduces Sorafenib’s Sensitivity of Esophageal Carcinoma Cells viaModulating the miR-29c-3p/COL11A1 Signaling Axis (2023 · Current Molecular Pharmacology · 被引 19)